Skip to main content
. 2020 Dec 2;102(3):351–358. doi: 10.1016/j.apmr.2020.11.005

Table 2.

Elixhauser comorbidities and discharge destination

Elixhauser Comorbidity (%) Discharge Home (n=165) Discharge Institution (n=65)
Fluid and electrolyte disorders 52.7 73.8
Hypertension, uncomplicated 38.2 32.3
Obesity 20.0 18.5
Cardiac arrhythmias 15.8 41.5
Chronic pulmonary disease 15.8 23.1
Diabetes, uncomplicated 15.2 9.2
Hypothyroidism 12.1 16.9
Diabetes, complicated 11.5 41.5
Coagulopathy 11.5 15.4
Renal failure 9.7 35.4
Congestive heart failure 9.1 24.6
Depression 7.3 18.5
Liver disease 6.7 1.5
Weight loss 5.5 18.5
Other neurologic disorders 4.2 32.3
Hypertension, complicated 4.2 24.6
Drug abuse 4.2 3.1
Valvular disease 3.6 3.1
AIDS/HIV 3.6 1.5
Peripheral vascular disease 3.0 9.2
Solid tumor without metastasis 3.0 3.1
Rheumatoid arthritis/collagen vascular diseases 2.4 6.2
Deficiency anemia 1.8 9.2
Lymphoma 1.8 0.0
Metastatic cancer 0.6 3.1
Pulmonary circulation disorders 0.6 1.5
Alcohol abuse 0.6 0.0
Blood loss anemia 0.6 0.0
Peptic ulcer disease, excluding bleeding 0.6 0.0
Paralysis 0.0 4.6
Psychoses 0.0 3.1